Zohydro ER Faces FDA Rejection


Zohydro ER Faces FDA Rejection

The Food and Drug Administration (FDA) is now opposing the Zohydro ER made by Zogenix Inc. which is stronger and new version of hydrocodone.

The drug was voted very low i. e. 11-2 with one nonparticipation. FDA received the suggestion of government pain expert panel over their rejection since the painkiller was reported to cause high levels of abuse.

Zogenix Inc. is based San Diego who developed the Zohyro ER capsules to cure average to chronic pains. The rejection has emerged as a vital setback for the drug maker since the trades of the drug have been stopped in wake of the news.

However, the FDA will make a final decision about the drug in March 2013 when it will tell whether the drug is safe for use. And if the drug gets the nod from the health officials, US will get its first pure hydrocodone painkiller while those in market as of now are of lower strength.

"There is a documented patient need for an extended-release hydrocodone medicine without acetaminophen. We remain confident in the measures we have proposed to support safe use of Zohydro ER", said Stephen Farr, the President and Chief Operating Officer of Zogenix.

The drugs with hyrocodone and other combinations come under Schedule III drugs while Zohydro ER shall be classified as schedule II drug as it is more powerful.

Latest News

United’s New CEO Oscar Muñoz Aims at Improving relation with Workers
The September Job Number Hint at a Sluggish Patch
First Data Launches its IPO, Targets to Raise Up to $3.7 Billion
ConAgra’s Head Quarter Move Announcement gets Positive but ‘Muted’
Dunkin’ Donut Franchisee Plans to Close One Hundred Stores
Mr. Munoz New CEO of United Airline says Things will Improve under his Leadershi
Reportedly Walmart is Planning to Trim Hundreds of Jobs at its Bentonville
The Government Looking Deeper into Safety Issues; Transportation Secretary
Data Shows Rise in Local Home Prices Slow Down but Surpass the U.S. Average
Oil Futures Drop as U.S. Inventories Show Build-up Surpassing Analysts
Gap’s, Old Navy Head, to Become the new CEO of Ralph Lauren Corp.
Majority of UAW Workers at Warren Truck and Mack Engine Plant Vote in Favor